Evidence map›Paper›PMID 38911865›Full record

ArticleFrontiers in immunology2024

Aging is associated with an insufficient early inflammatory response of lung endothelial cells in SARS-CoV-2 infection.

Saravanan Subramaniam, Devin Kenney, Archana Jayaraman, Aoife Kateri O'Connell, Sarah Walachowski, Paige Montanaro, Christoph Reinhardt, Giuseppe Colucci, Nicholas A Crossland, Florian Douam and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Angiogenesis in Lung Regeneration and Aging.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Saravanan SubramaniamPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Devin KenneyNational Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, United States.
Archana JayaramanPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Aoife Kateri O'ConnellNational Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, United States.
Sarah WalachowskiPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Paige MontanaroDepartment of Virology, Immunology and Microbiology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.
Christoph ReinhardtCenter for Thrombosis and Hemostasis, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Giuseppe ColucciOuter Corelab, Viollier AG, Allschwil, Switzerland.
Nicholas A CrosslandNational Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, United States.
Florian DouamNational Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA, United States.
Markus BosmannPulmonary Center, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, United States.

Funding

Vectra Polaris Quantitative Pathology Imaging SystemS10OD030269 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2021 to 2021
$402k
Ventana Discovery Ultra Research Autostainer: an Ex+ Core serviceS10OD026983 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2019 to 2019
$207k
NCATS NIH HHS 1UL1-TR001430NIAID NIH HHS K22-AI144050NIAID NIH HHS T32-AI007309NIH HHS 1K22-AI144050NIH HHS 1R01-HL141513NIH HHS 1R21-ES032882NIH HHS S10 OD026983NIH HHS S10-OD026983NIH HHS S10 OD030269NIH HHS S10-OD030269
6 · The paper itself

Abstract

Advanced age is associated with an increased susceptibility to Coronavirus Disease (COVID)-19 and more severe outcomes, although the underlying mechanisms are understudied. The lung endothelium is located next to infected epithelial cells and bystander inflammation may contribute to thromboinflammation and COVID-19-associated coagulopathy. Here, we investigated age-associated SARS-CoV-2 pathogenesis and endothelial inflammatory responses using humanized K18-hACE2 mice. Survival was reduced to 20% in aged mice (85-112 weeks) versus 50% in young mice (12-15 weeks) at 10 days post infection (dpi). Bulk RNA-sequencing of endothelial cells from mock and infected mice at 2dpi of both age groups (aged: 72-85 weeks; young: 15 weeks) showed substantially lower significant differentially regulated genes in infected aged mice than in young mice (712 versus 2294 genes). Viral recognition and anti-viral pathways such as RIG-I-like receptor signaling, NOD-like receptor signaling and interferon signaling were regulated in response to SARS-CoV-2. Young mice showed several fold higher interferon responses (

Indexed as

AgingCOVID-19Endothelial CellsLungSARS-CoV-2Angiotensin-Converting Enzyme 2AnimalsDisease Models, AnimalHumansInflammationMiceMice, TransgenicAngiotensin-Converting Enzyme 2cytokineshost-pathogen interactioninflammationpattern recognition receptorsthromboinflammation

Identifiers

PMID38911865
PMCPMC11190167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.